title: The influence of drug loading on formulation structure and aerosol performance in carrier based dry powder inhalers.
abstract: Previous studies have reported that carrier:drug ratio and carrier size influence the aerosol performance of dry powder inhalation systems. These previous studies were complicated by the heterogeneous nature of the carriers used, making it difficult to define an explicit relationship between parameters and performance. Here, the authors studied the influence of drug loading and carrier size on drug aerosol performance using homogeneous spherical model carriers. Different formulations containing drug (salbutamol sulphate) and carriers (polystyrene beads with median diameters of 82.8μm, 277.5μm and 582.9μm, respectively) were prepared by varying the ratio of carrier to drug (from ∼5:1 to ∼85:1). The surface morphology of the carrier particles and force of adhesion were investigated using atomic force microscopy, while the aerosol performance was evaluated using a multi-stage liquid impinger. The carrier surface morphology for all carrier sizes was homogenous with root-mean square roughness values ≤112nm. No significant difference in the force of adhesion between salbutamol sulphate and the three carrier sizes was observed. Significant differences in aerosol performance of salbutamol sulphate (measured as fine particle dose (FPD) and fraction (FPF)≤5μm) from the carriers were observed. Specifically, as carrier size increased FPF decreased. In comparison, as drug loading increased there was no change in FPF until a critical threshold was exceeded. Such observations suggest that: (A) aerosolisation performance is governed by carrier collisions and (B) when homogeneous carriers are used, the aerosol performance remains constant with respect to drug concentration, until the formulation transitions from an ordered mix to an agglomerated and/or segregated powder bed.
authors.affiliation: The University of Sydney, Sydney, NSW 2006, Australia. paul.young@sydney.edu.au
authors.forename: Paul M
authors.initials: PM
authors.lastname: Young
authors.forename: Owen
authors.initials: O
authors.lastname: Wood
authors.forename: Jesslynn
authors.initials: J
authors.lastname: Ooi
authors.forename: Daniela
authors.initials: D
authors.lastname: Traini
mesh_terms: D000336:Aerosols / Q000138:chemical synthesis* / Q000737:chemistry; D000420:Albuterol / Q000737:chemistry; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D004337:Drug Carriers / Q000138:chemical synthesis* / Q000737:chemistry; D058995:Dry Powder Inhalers / Q000379:methods*; D010316:Particle Size; D011137:Polystyrenes / Q000737:chemistry; D011208:Powders / Q000138:chemical synthesis / Q000737:chemistry; D013499:Surface Properties
chemical_list: D000336:Aerosols; D004337:Drug Carriers; D011137:Polystyrenes; D011208:Powders; D000420:Albuterol